Table: SCI Pharmtech 3Q Net Profit NT$43.7M Vs NT$14.0M
SCI Pharmtech Inc. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$503,145,000 NT$256,443,000 Pretax Profit NT$56,374,000 NT$17,805,000 Net Profit NT…
SCI Pharmtech Inc. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$503,145,000 NT$256,443,000 Pretax Profit NT$56,374,000 NT$17,805,000 Net Profit NT…